Your browser doesn't support javascript.
loading
Antibacterial and Anticancer Activities of Pleurocidin-Amide, a Potent Marine Antimicrobial Peptide Derived from Winter Flounder, Pleuronectes americanus.
Hsu, Hui-Chen; Chen, Ming-Hsin; Yeh, Ming-Lung; Chen, Wei-Jung.
Affiliation
  • Hsu HC; Department of Biotechnology and Animal Science, National Ilan University, Yilan 26047, Taiwan.
  • Chen MH; Department of Biotechnology and Animal Science, National Ilan University, Yilan 26047, Taiwan.
  • Yeh ML; Department of Laboratory Medicine, Yuanshan Branch, Veterans General Hospital, Yilan 264, Taiwan.
  • Chen WJ; Department of Biotechnology and Animal Science, National Ilan University, Yilan 26047, Taiwan.
Mar Drugs ; 20(8)2022 Aug 14.
Article in En | MEDLINE | ID: mdl-36005521
ABSTRACT
The extensive use of conventional antibiotics has led to the growing emergence of many resistant strains of pathogenic bacteria. Evidence suggests that cationic antimicrobial peptides (AMPs) have the greatest potential to serve as traditional antibiotic substitutes. Recent studies have also reported that certain AMPs have selective toxicity toward various types of cancer cells. The electrostatic attraction between the negatively charged membrane components and AMPs is believed to play a crucial role in the disruption of bacterial and cancer cell membranes. In the current study, we used a potent AMP called Pleurocidin (Ple) derived from winter flounder Pleuronectes americanus and its C-terminal-amidated derivative Pleurocidin-amide (Ple-a), and evaluated their antibacterial and anticancer activities. Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens, with MIC values ranging from 0.25 to 32 µg/mL. These peptides are also potent against several multidrug-resistant (MDR) bacterial strains, with MIC values ranging from 2 to 256 µg/mL. When used in combination with certain antibiotics, they exhibited a synergistic effect against MDR E. coli. Ple and Ple-a also showed notable cytotoxicity toward various cancer cell lines, with IC50 values ranging from 11 to 340 µM, while normal mouse fibroblast 3T3 cells were less susceptible to these peptides. Ple-a was then selected to study its anticancer mechanism toward A549 human lung adenocarcinoma cells. Western blot analysis and confocal microscopy showed that Ple-a could inhibit autophagy of A549 cells, and induce apoptosis 48 h after treatment. Our findings provided support for the future application of Ple-a as potential therapeutic agent for bacterial infections and cancer treatment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Flounder Limits: Animals / Humans Language: En Journal: Mar Drugs Journal subject: BIOLOGIA / FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: Taiwán

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Flounder Limits: Animals / Humans Language: En Journal: Mar Drugs Journal subject: BIOLOGIA / FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: Taiwán